Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

153.60
+0.30000.20%
Post-market: 153.600.00000.00%17:05 EDT
Volume:2.23M
Turnover:342.91M
Market Cap:17.17B
PE:73.35
High:156.01
Open:153.03
Low:149.25
Close:153.30
52wk High:166.25
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:0.90
T/O Rate:2.19%
Dividend:0.28
Dividend Rate:0.18%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:2.38
PE(LYR):74.25

Loading ...

Evercore ISI Adjusts Revvity Price Target to $165 From $125

MT Newswires Live
·
Yesterday

Revvity price target raised to $160 from $115 at Barclays

TIPRANKS
·
Yesterday

Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

Revvity Initiated at Outperform by William Blair

Dow Jones
·
Yesterday

Revvity to Host Investor Day Webcast for Investors

Reuters
·
Oct 06

Revvity, Inc. : William Blair Initiates Coverage with Outperform Rating

THOMSON REUTERS
·
Oct 06

William Blair Initiates Revvity at Outperform

MT Newswires Live
·
Oct 06

Revvity Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Oct 06

Revvity initiated with an Outperform at William Blair

TIPRANKS
·
Oct 06

How Child Diabetes Screening Launch At Revvity (RVTY) Has Changed Its Investment Story

Simply Wall St.
·
Oct 06

Revvity VP, CAO Anita Gonzales Disposes of USD 13,060 in Common Shares

Reuters
·
Oct 03

Press Release: Revvity to Hold Earnings Call on November 3, 2026

Dow Jones
·
Oct 02

Revvity to Host Earnings Call for Third-Quarter 2026 Results

Reuters
·
Oct 02

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 30

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)

TIPRANKS
·
Sep 26

Revvity Inc. Stock Climbs 6.0%, Outperforms Peers

Dow Jones
·
Sep 25

Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test

MT Newswires Live
·
Sep 25

Revvity Shares Rise on Launch of Child Type 1 Diabetes Screening Test

MT Newswires Live
·
Sep 24

Revvity launches GSP T1D 3plex kit

TIPRANKS
·
Sep 24

Leerink Partners Adjusts Revvity Price Target to $160 From $145, Maintains Outperform Rating

MT Newswires Live
·
Sep 24